Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nanus

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Clinical Genitourinary Cancer|May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinomaKevin A David, Matthew I Milowsky, David M Nanus
The Prostate|March 26, 2008
Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cellsAkio Horiguchi, Rong Zheng, Ruoqian Shen, et al.
International Journal of Oncology|September 20, 2024
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancerKatsuyuki Iida, Rong Zheng, Ruoqian Shen, et al.
Molecular and Cellular Endocrinology|September 5, 2006
Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoterRong Zheng, Ruoqian Shen, Oscar B Goodman, et al.
The Prostate|November 10, 2012
Negative regulation of NEP expression by hypoxiaRanjana Mitra, Olivia S Chao, David M Nanus, et al.
Seminars in Interventional Radiology|March 6, 2014
Immunologics and chemotherapeutics for renal cell carcinomaElan Diamond, Jamie Riches, Bishoy Faltas, et al.
Cancer Research|March 1, 2013
Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesisLeiping Fu, Gang Wang, Maria M Shevchuk, et al.
Molecular Cancer Research : MCR|February 27, 2015
Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC TranscriptomeLeiping Fu, Denise R Minton, Tuo Zhang, et al.
Cancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.
Cancer Research|September 13, 2011
Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1αLeiping Fu, Gang Wang, Maria M Shevchuk, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Clinical Genitourinary Cancer|May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinomaKevin A David, Matthew I Milowsky, David M Nanus
The Prostate|March 26, 2008
Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cellsAkio Horiguchi, Rong Zheng, Ruoqian Shen, et al.
International Journal of Oncology|September 20, 2024
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancerKatsuyuki Iida, Rong Zheng, Ruoqian Shen, et al.
Molecular and Cellular Endocrinology|September 5, 2006
Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoterRong Zheng, Ruoqian Shen, Oscar B Goodman, et al.
The Prostate|November 10, 2012
Negative regulation of NEP expression by hypoxiaRanjana Mitra, Olivia S Chao, David M Nanus, et al.
Seminars in Interventional Radiology|March 6, 2014
Immunologics and chemotherapeutics for renal cell carcinomaElan Diamond, Jamie Riches, Bishoy Faltas, et al.
Cancer Research|March 1, 2013
Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesisLeiping Fu, Gang Wang, Maria M Shevchuk, et al.
Molecular Cancer Research : MCR|February 27, 2015
Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC TranscriptomeLeiping Fu, Denise R Minton, Tuo Zhang, et al.
Cancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.
Cancer Research|September 13, 2011
Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1αLeiping Fu, Gang Wang, Maria M Shevchuk, et al.
Pageof 17